ArticleFrontiers in nutrition2026
Predicting extrauterine growth restriction at the parenteral-enteral nutrition transition: a model for risk identification in very preterm infants.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aims to identify the key predictors of longitudinal extrauterine growth restriction (EUGR) in very preterm infants during the parenteral-to-enteral nutrition transition and subsequently develop an effective predictive model for early clinical identification. Methods: A total of 260 infants born at 28-31 Results: The study identified six key predictors: gestational age, sex, time to regain birth weight, gestational diabetes, hypertensive disorders of pregnancy and blood urea nitrogen. Among the models compared, the logistic regression model exhibited the best performance, and the nomogram developed from this model demonstrated strong predictive efficacy. Conclusion: In this study, we developed and internally validated a prediction model for longitudinal EUGR in very preterm infants specifically during the parenteral-to-enteral transition. The model demonstrated robust predictive performance, strong clinical utility, and exceptional interpretability. It offers a practical tool for risk stratification during the parenteral-to-enteral transition, enabling clinicians to identify high-risk infants who may benefit from timely, personalized nutritional support.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.